Current landscape and future directions of neoantigen vaccines: A new era of personalized cancer immunotherapy.

Wang X, Su S, Tan S, Chen X, Wang L, Wang S, Chen F

Open source

DOI
10.1016/j.xinn.2026.101357
Published
2026 Sep 8
Container
Innovation (Cambridge (Mass.))
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.xinn.2026.101357,
  title = {Current landscape and future directions of neoantigen vaccines: A new era of personalized cancer immunotherapy.},
  author = {Wang X and Su S and Tan S and Chen X and Wang L and Wang S and Chen F},
  year = {2026},
  journal = {Innovation (Cambridge (Mass.))},
  doi = {10.1016/j.xinn.2026.101357},
  url = {https://doi.org/10.1016/j.xinn.2026.101357}
}

RIS

TY  - JOUR
TI  - Current landscape and future directions of neoantigen vaccines: A new era of personalized cancer immunotherapy.
AU  - Wang X
AU  - Su S
AU  - Tan S
AU  - Chen X
AU  - Wang L
AU  - Wang S
AU  - Chen F
PY  - 2026
JO  - Innovation (Cambridge (Mass.))
DO  - 10.1016/j.xinn.2026.101357
UR  - https://doi.org/10.1016/j.xinn.2026.101357
ER  - 

APA

X, W., S, S., S, T., X, C., L, W., S, W., & F, C. (2026). Current landscape and future directions of neoantigen vaccines: A new era of personalized cancer immunotherapy.. Innovation (Cambridge (Mass.)). https://doi.org/10.1016/j.xinn.2026.101357

Source records